Goldman Sachs’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Sell |
18,621
-4,982
| -21% | -$38K | ﹤0.01% | 4814 |
|
|
2025
Q1 | $76.9K | Sell |
23,603
-109,464
| -82% | -$357K | ﹤0.01% | 4865 |
|
|
2024
Q4 | $599K | Buy |
133,067
+348
| +0.3% | +$1.57K | ﹤0.01% | 4197 |
|
|
2024
Q3 | $368K | Sell |
132,719
-129,369
| -49% | -$358K | ﹤0.01% | 4255 |
|
|
2024
Q2 | $896K | Buy |
262,088
+232,342
| +781% | +$795K | ﹤0.01% | 3634 |
|
|
2024
Q1 | $161K | Buy |
+29,746
| New | +$161K | ﹤0.01% | 4385 |
|
|
2023
Q4 | – | Sell |
-19,654
| Closed | -$173K | – | 4902 |
|
|
2023
Q3 | $173K | Buy |
+19,654
| New | +$173K | ﹤0.01% | 4287 |
|